These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cells for tissue engineering of cardiac valves. Jana S; Tranquillo RT; Lerman A J Tissue Eng Regen Med; 2016 Oct; 10(10):804-824. PubMed ID: 25712485 [TBL] [Abstract][Full Text] [Related]
5. Current Status of Tissue Engineering Heart Valve. Shinoka T; Miyachi H World J Pediatr Congenit Heart Surg; 2016 Nov; 7(6):677-684. PubMed ID: 27834758 [TBL] [Abstract][Full Text] [Related]
6. [Tissue engineering for heart valves and vascular grafts]. Teebken OE; Wilhelmi M; Haverich A Chirurg; 2005 May; 76(5):453-66. PubMed ID: 15841408 [TBL] [Abstract][Full Text] [Related]
7. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187 [TBL] [Abstract][Full Text] [Related]
8. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156 [TBL] [Abstract][Full Text] [Related]
9. Bioengineered living cardiac and venous valve replacements: current status and future prospects. Kehl D; Weber B; Hoerstrup SP Cardiovasc Pathol; 2016; 25(4):300-305. PubMed ID: 27167776 [TBL] [Abstract][Full Text] [Related]
10. Biomechanical conditioning of tissue engineered heart valves: Too much of a good thing? Parvin Nejad S; Blaser MC; Santerre JP; Caldarone CA; Simmons CA Adv Drug Deliv Rev; 2016 Jan; 96():161-75. PubMed ID: 26555371 [TBL] [Abstract][Full Text] [Related]
11. Biological and mechanical evaluation of a Bio-Hybrid scaffold for autologous valve tissue engineering. Jahnavi S; Saravanan U; Arthi N; Bhuvaneshwar GS; Kumary TV; Rajan S; Verma RS Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():59-71. PubMed ID: 28183649 [TBL] [Abstract][Full Text] [Related]
12. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute. Breuer CK; Mettler BA; Anthony T; Sales VL; Schoen FJ; Mayer JE Tissue Eng; 2004; 10(11-12):1725-36. PubMed ID: 15684681 [TBL] [Abstract][Full Text] [Related]
14. A review of: application of synthetic scaffold in tissue engineering heart valves. Fallahiarezoudar E; Ahmadipourroudposht M; Idris A; Mohd Yusof N Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():556-65. PubMed ID: 25579957 [TBL] [Abstract][Full Text] [Related]
15. Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells. Wu KH; Liu YL; Zhou B; Han ZC Eur J Cardiothorac Surg; 2006 Nov; 30(5):770-81. PubMed ID: 16963271 [TBL] [Abstract][Full Text] [Related]
16. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763 [TBL] [Abstract][Full Text] [Related]